UCB Logo

UCB

🇧🇪
UCB
BE0003739530

UCB is a global biopharmaceutical company headquartered in Belgium. It focuses on the research and development of innovative medicines for patients with severe diseases in immunology and neurology to sustainably improve their quality of life.

Next Quarterly Earnings

Thursday, February 25, 2027
CW 8
In 182 days
Confirmed by the company

Date confirmed from the company's own financial calendar.

Quiet period starts on January 28, 2027

Stock Price

Frequently asked questions

When will UCB report its next quarterly earnings?

UCB is scheduled to report its next quarterly earnings on 02/25/2027.

When did UCB last report quarterly earnings?

UCB last reported quarterly earnings on 7/30/2026 (Q2 2026). Earnings per share (EPS) came in at 6.84 EUR.

How do I add the UCB earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q2 2026
Beat
Estimate:€5.09
Actual:€6.84
Difference:+€1.76
Price reaction (1 day):-13.5 %
Price reaction (7 days):-10.3 %
Q4 2025
Estimate:
Actual:€6.46
Price reaction (1 day):-7.9 %
Price reaction (7 days):-4.4 %

Company Information

Name
UCB
Ticker Symbol
UCB
ISIN
BE0003739530
Country
🇧🇪
Belgium
Sector
More Financial Information